ARTICLE SUMMARY:
Medtronic is counting on its long-awaited Liberant intelligent peripheral thrombectomy platform, supported by Contego’s Excipio device, to be the flagship of growing peripheral and venous thrombectomy business.
Medtronic is investing in peripheral and venous thrombectomy technology to gain a foothold in another fast-growing cardiovascular market.
